Yashas Rajendra Ph.D.Associate Director & Principal Scientist at Denali TherapeuticsSpeaker
Profile
Yashas obtained his B.E. in India, MS in Stockholm and Ph.D. from the Swiss Federal Institute (EPFL), Lausanne under guidance of Prof. Florian Wurm focused on recombinant protein expression. He worked at Eli Lilly for about 5 years in R&D. He joined Denali in 2018 where he currently leads cell line and cell culture process development of complex biologics.
Agenda Sessions
Chairperson's Remarks
, 10:25amView SessionSialic acid modulation for enzyme fusions using combined approach of cell line engineering and cell culture process development
, 10:30amView SessionSialic acid modulation for enzyme fusions using combined approach of cell line engineering and cell culture process development
, 10:30amView Session